PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis With Its Microarray Detection Platform
November 12, 2024
November 12, 2024
SAN ANTONIO, Texas, Nov. 12 -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services, issued the following news release on Nov. 11, 2024:
* * *
PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis.
* * *
Frost & Sullivan recently assessed the multiplexed uri . . .
* * *
PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis.
* * *
Frost & Sullivan recently assessed the multiplexed uri . . .